Kymera Therapeutics, Inc. · NASDAQ:KYMR
Rooney Terence received 38,000 Kymera Therapeutics, Inc. shares as an award (Form 4)
Traded Jul 27, 2026 · Filed Jul 27, 2026
On Jul 27, 2026, Rooney Terence (Chief Medical Officer) received 38,000 Kymera Therapeutics, Inc. shares as an award, leaving 38,000 shares. Filed Jul 27, 2026 (Form 4).
- Awarded
- 38,000 shares
- Holding after
- 38,000 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 27, 2026 | Common Stock | Award | 38,000 | 38,000 | Direct |
Source
Related
- Kymera Therapeutics, Inc.
- Rooney Terence
- Kymera Therapeutics, Inc. shareholders
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026